Fig. 4From: Construction and validation of a cuproptosis-related five-lncRNA signature for predicting prognosis, immune response and drug sensitivity in breast cancerThe prognostic value of lncRNA signature. Kaplan–Meier survival analysis compared low risk and high risk groups in all A, test B, train C groups, and PFS D in all samples)Back to article page